Evidence map›Paper›PMID 35401517›Full record

ArticleFrontiers in immunology2022

Balancing the View of C1q in Transplantation: Consideration of the Beneficial and Detrimental Aspects.

Raneem Khedraki, Hirotsugu Noguchi, William M Baldwin

Abstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Raneem KhedrakiDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
Hirotsugu NoguchiDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.
William M BaldwinDepartment of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States.

Funding

Surgery CoreP01AI087586 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI VALUJSKIKH, ANNA · 2010 to 2019
$17.2M
Complement regulates macrophage and platelet function in kidney transplantsR01AI165513 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI BALDWIN, WILLIAM M · 2021 to 2025
$3.1M
NIAID NIH HHS P01 AI087586NIAID NIH HHS R01 AI165513
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Complement C1qIsoantibodiesGraft RejectionComplement C1qIsoantibodiesantibody-mediated rejectionB cellsC1qcomplementdonor specific antibodiespattern recognition receptortissue resident macrophages

Identifiers

PMID35401517
PMCPMC8988182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.